mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
JNK-9L |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.003 |